BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 8:07:00 PM | Browse: 1695 | Download: 2023
 |
Received |
|
2012-08-06 21:32 |
 |
Peer-Review Started |
|
|
|
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
|
|
Revised |
|
|
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2012-09-28 09:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2012-09-28 11:36 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2012-11-28 15:16 |
|
Publish the Manuscript Online |
|
2012-12-18 12:04 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Telaprevir/boceprevir era: From bench to bed and back
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Qiuwei Pan, Maikel P Peppelenbosch, Harry LA Janssen and Robert J de Knegt |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Foundation for Liver and Gastrointestinal Research (SLO) |
|
| The Netherlands Organisation for Scientific Research (NWO) |
VENI-grant 916-13-032 (to Pan Q) |
|
| Corresponding Author |
Qiuwei Pan, PhD, Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Room L-462, ’s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. q.pan@erasmusmc.nl |
| Key Words |
Telaprevir; Boceprevir; Mechanism-of-action; Clinical efficacy; Liver transplantation patient; Interferon; Ribavirin |
| Core Tip |
|
| Publish Date |
2012-12-18 12:04 |
| Citation |
Pan Q, Peppelenbosch MP, Janssen HLA, de Knegt RJ. Telaprevir/ boceprevir era: From bench to bed and back. World J Gastroenterol 2012; 18(43): 6183-6188 |
| URL |
http://www.wjgnet.com/1007-9327/full/v18/i43/6183.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v18.i43.6183 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
